MetaCap

Who Owns Climb Bio Stock?

NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.19-0.09 (-0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
117.94%
Institutional holders
173
  • Institutions 99.8%
  • Insiders 0.2%
  • Public and other 0.0%

Who owns Climb Bio stock?

Institutional investors own about 117.9% of Climb Bio's shares, spread across 173 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.17% of CLYM.

The largest institutional holders are RA Capital Management, L.P. (17.25%), FMR, LLC (15.78%) and UBS Group AG (7.64%). Together, the top 10 institutions control 70.6% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their CLYM positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CLYM

Climb Bio top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.10.13M17.25%-10.4%
FMR, LLC9.27M15.78%+36.5%
UBS Group AG4.49M7.64%+31.9%
Blackrock Inc.2.94M5.00%+24.7%
Braidwell LP 2.86M4.87%+2.4%
Woodline Partners LP2.73M4.65%+72.6%
Price (T.Rowe) Associates Inc2.42M4.12%+13.7%
Vanguard Capital Management LLC2.38M4.04%+39.9%
Adage Capital Partners GP L.L.C.2.17M3.69%-13.5%
Cormorant Asset Management, LP2.11M3.59%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CLYM

Climb Bio top fund holders
FundShares% Held
Fidelity Securities Fund-Fidelity Small Cap Growth Fund1.88M3.21%
T. Rowe Price Health Sciences Fund, Inc.1.64M2.79%
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund1.53M2.60%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.37M2.33%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.08M1.83%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund996.40K1.70%
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund977.59K1.66%
iShares Trust-iShares Russell 2000 ETF959.32K1.63%
Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund876.30K1.49%
Fidelity Select Portfolios-Select Biotechnology Portfolio721.30K1.23%

Frequently asked questions

Who is the largest shareholder of Climb Bio?

RA Capital Management, L.P. is the largest institutional shareholder of CLYM, owning 17.25% of shares outstanding (10.13M shares) as of its latest 13F filing.

What percentage of Climb Bio is owned by institutions?

Institutions own about 117.9% of CLYM shares and 118.2% of the public float.

How much of Climb Bio do insiders own?

Insiders, such as officers and directors, own about 0.17% of CLYM shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related